iTeos Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops innovative medicines for the treatment of cancer. The company is focused on developing small molecule therapies that modulate immunological pathways for the treatment of solid tumors and hematological malignancies. iTeos Therapeutics is headquartered in Brussels, Belgium and has operations in Cambridge, Massachusetts.